Effect of Short Term Sibutramine Supplementation on Appetite Suppression and Related Metabolic Responses
DOI:
https://doi.org/10.6000/1927-5951.2012.02.02.8Keywords:
Sibutramine hydrochloride monohydrate, obesity, appetite, leptin, ghrelin, adiponectin.Abstract
The appetite suppressing property of Sibutramine is well reported. The present study was undertaken to investigate the appetite regulatory mechanism and associated metabolic changes induced in male Sprague Dawley rats by its short term supplementation. The effect of the drug on the regulatory hormones and biochemical variables was studied at an oral dose of 10 mg/kg body weight. There was a decrease in food intake of rats by 35.5% in comparison to their basal food intake as well as untreated controls. There was an increase in plasma levels of adiponectin, serotonin and a decrease in IGF-1 and corticosterone in the treated animals. The circulating levels of ghrelin marginally decreased with a corresponding increase in leptin and CCK in case of treated rats. These may be responsible for the anorectic effect of the drug.
References
Równicka-Zubik J, Góra A, Su?kowska A. The obesity and way for treatment. Wiad Lek 2011; 64: 226-30.
Roh C, Jung U, Jo SK. Screening of anti-obesity agent from herbal mixtures. Molecules 2012; 17: 3630-38. http://dx.doi.org/10.3390/molecules17043630
Harrold JA, Dovey TM, Blundell JE, Halford JC. CNS regulation of appetite. Neuropharmacology 2012; 63: 3-17. http://dx.doi.org/10.1016/j.neuropharm.2012.01.007
Oltmanns KM, Heldmann M, Daul S, et al. Sibutramine promotes amygdala activity under fasting conditions in obese women. Psychopharmacology (Berl) 2012; 221: 693-700. http://dx.doi.org/10.1007/s00213-011-2615-7
McGovern L, Johnson JN, Paulo R, et al. Clinical review: treatment of pediatric obesity: a systematic review and meta-analysis of randomized trials. J Clin Endocrinol Metab 2008; 12: 4600-605. http://dx.doi.org/10.1210/jc.2006-2409
Kanekar A, Sharma M. Pharmacological approaches for management of child and adolescent obesity. J Clin Med Res 2010; 2: 105-11.
McTigue KM, Harris R, Hemphill B, et al. Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2003; 139: 933-49.
Barkeling B, Elfhag K, Rooth P, Rössner S. Short-term effects of sibutramine (Reductil) on appetite and eating behavior and the long-term therapeutic outcome. Int J Obes Relat Metab Disord 2003; 27: 693-700. http://dx.doi.org/10.1038/sj.ijo.0802298
Suliburska J, Bogda?ski P, Szuli?ska M, Pupek-Musialik D. Short-Term Effects of Sibutramine on Mineral Status and Selected Biochemical Parameters in Obese Women. Biol Trace Elem Res 2012; in press. http://dx.doi.org/10.1007/s12011-012-9425-6
Joo NS, Kim SM, Kim KM, Kim CW, Kim BT, Lee DJ. Changes of body weight and inflammatory markers after 12-week intervention trial: results of a double-blind, placebo-control pilot study. Yonsei Med J 2011; 52: 242-48. http://dx.doi.org/10.3349/ymj.2011.52.2.242
Weeke P, Andersson C, Fosbøl EL, et al. The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period. BMC Endocr Disord 2010; 10: 3. http://dx.doi.org/10.1186/1472-6823-10-3
Rotstein A, Inbar O, Vaisman N. The effect of sibutramine intake on resting and exercise physiological responses. Ann Nutr Metab 2008; 52: 17-23. http://dx.doi.org/10.1159/000114290
Fischer K, Colombani PC, Wenk C. Metabolic and cognitive coefficients in the development of hunger sensations after pure macronutrient ingestion in the morning. Appetite 2004; 42: 49-61. http://dx.doi.org/10.1016/S0195-6663(03)00116-8
Luscombe GP, Hopcroft RH, Thomas PC, Buckett WR. The contribution of metabolites to the rapid and potent down-regulation of rat cortical ?-adrenoceptors by the putative antidepressant sibutramine hydrochloride. Neuropharmacology 1989; 28: 129-34. http://dx.doi.org/10.1016/0028-3908(89)90048-8
Casado A, Rodríguez VM, Portillo MP, et al. Sibutramine decreases body weight gain and increases energy expenditure in obese Zucker rats without changes in NPY and orexins. Nutr Neurosci 2003; 6: 103-11. http://dx.doi.org/10.1080/1028415031000094264
LeBlanc M, Thibault L. Effect of sibutramine on macronutrient selection in male and female rats. Physiol Behav 2003; 80: 243-52. http://dx.doi.org/10.1016/j.physbeh.2003.07.010
Montogomery R. Determination of glycogen. Arch Biochem Biophys 1957; 67: 378-86. http://dx.doi.org/10.1016/0003-9861(57)90292-8
Halperin ML, Pande SV. Fatty acyl group transport in mitochondria: carnitine palmitoyltransferase EC 2.3.1.23 and the carnitine-acylcarnitine translocase. Methods Enzymol 1979; 56: 368-78. http://dx.doi.org/10.1016/0076-6879(79)56034-0
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-75.
Mulla MSA, Goyal VK, Jana S, Nirogi R. Safety Evaluation of Sibutramine in Wistar Rats. African J Basic Appl Sci 2010; 2: 128-34.
Levin BE, Dunn-Meynell AA. Sibutramine alters the central mechanisms regulating the defended body weight in diet-induced obese rats. Am J Physiol Regul Integr Comp Physiol 2000; 279: R2222-R2228.
Padwal RS, Majumdar SR. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 2007; 369: 71-77. http://dx.doi.org/10.1016/S0140-6736(07)60033-6
Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000; 404: 661-71.
Chapelot D, Marmonier C, Thomas F, Hanotin C. Modalities of the food intake-reducing effect of sibutramine in humans. Physiol Behav 2000; 68: 299-308. http://dx.doi.org/10.1016/S0031-9384(99)00176-6
Frassetto SS, Della Santa Rubio A, Lopes JJ, et al. Locomotor and peripheral effects of sibutramine modulated by 5-HT2 receptors. Can J Physiol Pharmacol 2006; 84: 1239-44. http://dx.doi.org/10.1139/y06-082
Fabris R, Granzotto M, Pagano C, et al. Effect of sibutramine on glucose metabolism in genetically obese (fa/fa) Zucker rats. Int J Obes Relat Metab Disord 2000; 24: S124-S126. http://dx.doi.org/10.1038/sj.ijo.0801297
Godoy-Matos A, Carraro L, Vieira A, et al. Treatment of obese adolescents with sibutramine: a randomized, double-blind controlled study. J Clin Endocrinol Metab 2005; 90: 1460-65. http://dx.doi.org/10.1210/jc.2004-0263
Berkowitz RI, Wadden TA, Tershakovec AM, Cronquist JL. Behavior therapy and sibutramine for the treatment of adolescent obesity. JAMA 2003; 289: 1805-12. http://dx.doi.org/10.1001/jama.289.14.1805
Anagnostis P, Selalmatzidou D, Sapranidis M, et al. Comparative effects of sibutramine and orlistat on weight loss, glucose metabolism and leptin levels in non-diabetic obese patients: A prospective study. Indian J Endocrinol Metab 2012; 16: 146-47. http://dx.doi.org/10.4103/2230-8210.91214
Berkowitz RI, Fujioka K, Daniels SR, et al. Effects of sibutramine treatment in obese adolescents: a randomized trial. Ann Intern Med 2006; 145: 81-90.
Smith WJ, Underwood LE, Clemmons DR. Effects of caloric or protein restriction on insulin like growth factor-1 (IGF-1) and IGF binding proteins in children and adults. J Clin Endocrinol Metab 1995; 80: 443-49. http://dx.doi.org/10.1210/jc.80.2.443
Baranowska B, Woli?ska-Witort E, Marty?ska L, et al. Sibutramine therapy in obese women--effects on plasma neuropeptide Y (NPY), insulin, leptin and beta-endorphin concentrations. Neuro Endocrinol Lett 2005; 26: 675-79.
Stroubini T, Perrea D, Perelas A, et al. Effect of sibutramine on regional fat pads and leptin levels in rats fed with three isocaloric diets. Eur Cytokine Netw 2008; 19: 149-55.
Sari R, Eray E, Ozdem S, Akbas H, Coban E. Comparison of the effects of sibutramine versus sibutramine plus metformin in obese women. Clin Exp Med 2010; 10: 179-84. http://dx.doi.org/10.1007/s10238-009-0080-y
Derosa G, Maffioli P, Ferrari I, et al. Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients. J Clin Pharm Ther 2011; 36: 592-601. http://dx.doi.org/10.1111/j.1365-2710.2010.01217.x
Bush EN, Shapiro R, Brune ME, et al. Chronic treatment with either dexfenfluramine or sibutramine in diet-switched diet-induced obese mice. Endocrine 2006; 29: 375-81. http://dx.doi.org/10.1385/ENDO:29:2:375
Zanella MT, Ribeiro Filho FF. Emerging drugs for obesity therapy. Arq Bras Endocrinol Metab 2009; 53: 271-80. http://dx.doi.org/10.1590/S0004-27302009000200019
Halford JC, Wanninayake SC, Blundell JE. Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake. Pharmacol Biochem Behav 1998; 61: 159-68. http://dx.doi.org/10.1016/S0091-3057(98)00032-X
Guo H, Liu G, Zhong R, Wang Y, Wang D, Xia M. Cyanidin-3-O-?-glucoside regulates fatty acid metabolism via an AMP-activated protein kinase-dependent signaling pathway in human HepG2 cells. Lipids Health Dis 2012; 11: 10. http://dx.doi.org/10.1186/1476-511X-11-10
Kang JA, Lee K, Lee KM, et al. Desipramine Inhibits Histamine H1 Receptor-Induced Ca2+. Signaling in Rat Hypothalamic Cells. PLoS One 2012; 7: e36185. http://dx.doi.org/10.1371/journal.pone.0036185
Kim DM, Yoon SJ, Ahn CW, et al. Sibutramine improves fat distribution and insulin resistance, and increases serum adiponectin levels in Korean obese nondiabetic premenopausal women. Diabetes Res Clin Pract 2004; 66: S139-S144. http://dx.doi.org/10.1016/j.diabres.2003.12.008
Polyzos SA, Kountouras J, Zavos C, Tsiaousi E. The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease. Diabetes Obes Metab 2010; 12: 365-383. http://dx.doi.org/10.1111/j.1463-1326.2009.01176.x
Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 2003; 112: 91-100.
Amin A, Dhillo WS, Murphy KG. The central effects of thyroid hormones on appetite. J Thyroid Res 2011; 2011: 306510.
Grover GJ, Mellström K, Malm J. Therapeutic potential for thyroid hormone receptor-beta selective agonists for treating obesity, hyperlipidemia and diabetes. Curr Vasc Pharmacol 2007; 5: 141-54. http://dx.doi.org/10.2174/157016107780368271
Saleh A, Bisher AB. The Physiological alterations induced by Sibutramine anti-obesity drug on the functions of the thyroid gland and the liver: An experimental study on Wistar rats. Indian J Sci Technol 2010; 3: 1129-33.
Keskin L, Sahin I, Bentli R, Senel S, Taskapan C. The effects of orlistat and sibutramine on serum thyroid hormone levels in obese subjects. Endocrine Abstracts, European Congress of Endocrinology; 2006: Glasgow, UK: British Endocrine Societies 2006; 11: P853.
Maes M, Meltzer HY, D'Hondt P, Cosyns P, Blockx P. Effects of serotonin precursors on the negative feedback effects of glucocorticoids on hypothalamic-pituitary-adrenal axis function in depression. Psychoneuroendocrinology 1995; 20: 149-67. http://dx.doi.org/10.1016/0306-4530(94)00049-G
Dronjak S, Spasojevic N, Gavrilovic L, Varagic V. Effects of noradrenaline and serotonin reuptake inhibitors on pituitary-adrenocortical and sympatho-adrenomedullar system of adult rats. Neuro Endocrinol Lett 2007; 28: 614-20.
Fernstrom JD, Fernstrom MH. Monoamines and protein intake: are control mechanisms designed to monitor a threshold intake or a set point? Nutr Rev 2001; 59: S60-5, S66-8.
Downloads
Published
Issue
Section
License
Copyright (c) 2012 Swati Jain, Saroj K. Verma, Vijay K. Singh , Som Nath Singh

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Similar Articles
- Muriyati , Arimbi, Asnidar, Safruddin, Andi Imam Arundhana Thahir, The Association between Adiponectin Gene Polymorphism and Waist Circumference Changes in Obese/Overweight Adults after Aerobic Exercise and Diet Treatment , Journal of Pharmacy and Nutrition Sciences : Vol. 9 No. 5 (2019)
- Arianne N. Theodorous, David M. Schwartzberg , Sathyaprasad C. Burjonrappa, The Hunger Games: A Systematic Review of Pediatric Bariatric Surgery , Journal of Pharmacy and Nutrition Sciences : Vol. 5 No. 2 (2015)
- George Aboagye, Gloria Pobee, Jonathan Annan-Asare, Theodosia Adom, Assessment of Obesity Among Pregnant Women in the Volta Region of Ghana , Journal of Pharmacy and Nutrition Sciences : Vol. 14 (2024)
- Muhammad Farhan, Hamna Rafiq , Hira Rafi, Prevalence of Depression in Animal Model of High Fat Diet Induced Obesity , Journal of Pharmacy and Nutrition Sciences : Vol. 5 No. 3 (2015)
- Sara Tutunchi, Mehdi Koushki, Nasrin Amiri-Dashatan, Hadi Khodabandehloo, Hossein Hosseini, Godratollah Panahi, Javad Hashemi, Amir Karbalaee-Hasani, Ziba Majidi, Mostafa Rezaei-Tavirani, Effect of Soy Isoflavones Supplementation on Adiponectin Levels in Postmenopausal Women , Journal of Pharmacy and Nutrition Sciences : Vol. 11 (2021)
- Kenichiro Yasutake, Motoyuki Kohjima, Yusuke Murata, Manabu Nakashima, Makoto Nakamuta , Munechika Enjoji, Association between Visceral Fat and Body Mass Index in Patients with Cirrhosis , Journal of Pharmacy and Nutrition Sciences : Vol. 4 No. 1 (2014)
- Mumtaz Hussain , Shariza Sahudin, Obesity, Type-II Diabetes and the Use of Food Labels: A Malaysian Perspective , Journal of Pharmacy and Nutrition Sciences : Vol. 9 No. 3 (2019)
- Alexander V. Oleskin, Andrey L. Postnov, Cao Boyang, Impact of Biogenic Amines on the Growth of Green Microalgae , Journal of Pharmacy and Nutrition Sciences : Vol. 11 (2021)
- Wensheng Li, Eric Blough, Cuifen Wang, Larry Dial, Omolola Olajide, Randa Al-Jayoussi, Nesreen BenHamed , Miaozong Wu, Oxidative Stress Promotes Eating Behavior and Obesity in C. elegans via EGL-4 / DAF-16 Signaling , Journal of Pharmacy and Nutrition Sciences : Vol. 5 No. 2 (2015)
- Laura-Isabel Arranz , Miguel-Ángel Canela , Magda Rafecas, Fibromyalgia and Diet-Related Diseases: Does Health Professional Advice Make Sense? , Journal of Pharmacy and Nutrition Sciences : Vol. 1 No. 2 (2011)
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Archana Singh, Saroj Kumar Verma, Vijay Kumar Singh, Chindalaga Nanjappa, Nagraj Roopa, Pakalpati Srinivas Raju , Som Nath Singh, Beetroot Juice Supplementation Increases High Density Lipoprotein-Cholesterol and Reduces Oxidative Stress in Physically Active Individuals , Journal of Pharmacy and Nutrition Sciences : Vol. 5 No. 3 (2015)